Su1589 EFFECT OF PEMAFIBRATE, A SELECTIVE PEROXISOME PROLIFERATORACTIVATED RECEPTOR ALPHA MODULATOR (SPPARMA), ON THE LIPID PROFILE, LIVER FUNCTION, AND LIVER FIBROSIS AMONG PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Conference Poster (Faculty180)